Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone

J Allergy Clin Immunol. 2015 Aug;136(2):505-7. doi: 10.1016/j.jaci.2015.02.009. Epub 2015 Mar 29.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Anti-Asthmatic Agents / therapeutic use*
  • Aryl Hydrocarbon Hydroxylases / genetics
  • Aryl Hydrocarbon Hydroxylases / immunology
  • Asthma / drug therapy*
  • Asthma / genetics*
  • Asthma / immunology
  • Asthma / pathology
  • Beclomethasone / therapeutic use*
  • Child
  • Child, Preschool
  • Cytochrome P-450 CYP3A / genetics*
  • Cytochrome P-450 CYP3A / immunology
  • Disease Management
  • Female
  • Gene Expression
  • Humans
  • Male
  • Polymorphism, Single Nucleotide*
  • Treatment Outcome

Substances

  • Anti-Asthmatic Agents
  • Aryl Hydrocarbon Hydroxylases
  • CYP3A5 protein, human
  • CYP3A7 protein, human
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Beclomethasone